Opioid addiction treatments face off in US trial
CHICAGO - The first U.S. study to compare two treatments for opioid addiction finds a monthly shot works as well as a daily drug to prevent relapse.
The shot requires days of detox first and that proved to be a stumbling block for many. For those who made it, the shot Vivitrol worked about the same as an older treatment, Suboxone.
Both drugs had high relapse rates and there were overdoses, including fatal ones, in the experiment in 570 adults. It's the first to compare the two treatments in the U.S.
Study co-author Dr. Joshua Lee of New York University School of Medicine says it's time to broaden access to both treatments. Many treatment programs don't offer either medication.
The study was published Tuesday in the journal Lancet.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
LSU caretakers respond to Mike the Tiger pouncing video
Some Metro Councilmemebers like new road tax plan better than last one
Asian carp a growing concern for fisherman
Remains of local Marine killed in car crash return home Wednesday
Raising Cane's employees fired over video showing unsanitary behavior
LSU Track star Aleia Hobbs happy she could represent her home state...
14-year-old CoCo Gauff wants to be the next star in pro tennis
Pete Jenkins reflects on 2017 season
Temeka Johnson basketball camp about more than the game
Saints looking to fill backfield void during Ingram's 4-game absence